Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
1. A retrospective study was conducted to explore the importance of CYP2C9 genotyping for the initiation and maintenance therapy of warfarin in clinical practice. A total of 191 patients on warfarin therapy in a local hospital were recruited after written informed consent. Their medical records were...
Main Authors: | Ngow, Harris Abdullah, Teh , Lay Kek, Langmia, I. M., Lew, W. L., Harun, R., Ismail, R., Salleh, Mohd Zaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Informa Plc.
2008
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5015/ http://irep.iium.edu.my/5015/ http://irep.iium.edu.my/5015/ http://irep.iium.edu.my/5015/1/Xenobiotica_Warfarin_Study.pdf |
Similar Items
-
CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
by: Ngow, Harris Abdullah, et al.
Published: (2009) -
Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
by: Salleh, Mohd Zaki, et al.
Published: (2009) -
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011) -
VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010) -
High occurrence of CYP3A5 variants among breast cancer and organ transplant patients
by: Ismail, S, et al.
Published: (2010)